New Lantern
AI NativeKeep your eyes on the images. Let AI do the rest. New Lantern the first AI Radiology Resident.
Est 2021|Valuation $74M|Raised $22.6M
Published Sep 19, 2026
New Lantern is relatively new in the market, and mainstream review platforms (G2, TrustRadius, Gartner Peer Insights) did not show prominent, product-specific review pages for New Lantern in accessible searches. This may indicate limited review volume, product naming ambiguity, or gated platform access.
A discussion thread in an industry community forum raised questions about real-world integration capabilities, including whether New Lantern supports interfacing with third-party dictation/reporting systems such as PowerScribe. Responses in that thread suggested limited or unclear third-party reporter integration, which some commenters identified as a potential adoption risk for organizations standardized on incumbent reporting workflows.
No detailed, independently verifiable case studies (with methodology, baselines, and externally validated metrics) were located in the publicly accessible sources reviewed for this research.
Most plausible ICP (inferred):
Get a comprehensive analysis of New Lantern including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →The vendor’s website includes selected testimonials attributed to named clinicians. These are vendor-selected and not independent reviews. Summaries of the vendor-published testimonial content include:
These testimonials reflect vendor-selected customer experiences and should be validated via independent references and pilot evaluations.
Vendor and press materials include claims such as:
Critical evaluation: these claims lack publicly disclosed methodology (case mix, baselines, definitions of automation, study volumes, and measurement approaches). Buyers should request methodology, raw data, and referenceable customer studies during due diligence.
New Lantern is a cloud-native radiology platform that combines a PACS viewer, worklist/routing, and AI-assisted reporting into a single product. The vendor describes the core objective as reducing radiologists’ administrative and repetitive tasks (measurements, comparison/disease evolution analysis, and report drafting) to enable radiologists to allocate more time to image interpretation.
On its product site, New Lantern lists feature areas and capabilities including:
Important caveat: Many performance and automation metrics cited by the vendor are vendor-claimed and not independently validated in public sources.